{
    "status": "ok",
    "totalResults": 23,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Tandem Diabetes Care (NASDAQ:TNDM) Shares Down 2.3%",
            "description": "Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) fell 2.3% during trading on Friday . The stock traded as low as $18.49 and last traded at $18.61. 35,383 shares traded hands during mid-day trading, a decline of 97% from the average session\u2026",
            "url": "https://www.etfdailynews.com/2023/11/24/tandem-diabetes-care-nasdaqtndm-shares-down-2-3/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tandem-diabetes-care-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-24T16:50:59Z",
            "content": "Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) fell 2.3% during trading on Friday . The stock traded as low as $18.49 and last traded at $18.61. 35,383 shares traded hands durin\u2026 [+6036 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Minneapolis Star Tribune"
            },
            "author": "Burl Gilyard",
            "title": "Can Medtronic revive its beleaguered diabetes unit?",
            "description": "The MiniMed 780G insulin pump was approved in the spring, after several years of disruption for the diabetes business, including issues with the Food and Drug Administration.",
            "url": "https://www.startribune.com/can-medtronic-revive-its-beleaguered-diabetes-unit/600320785/",
            "urlToImage": "https://chorus.stimg.co/25084805/1016944754_med1.jpg?h=630&w=1200&fit=crop&bg=999&crop=faces",
            "publishedAt": "2023-11-18T12:00:00Z",
            "content": "Medtronic is showing signs of reaching a turning point in a market that it pioneered diabetes care after several years of critical setbacks.\r\nThe company's latest insulin pump came on the market late\u2026 [+8101 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "TNDM DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM",
            "description": "(marketscreener.com) \n\nNEW YORK, Nov. 7, 2023 /PRNewswire/ --\n\n \n \n \n \n \n \n\n \nWHY:\u00a0Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. between August 3, 2022 and November 2, 2022, both dates inclus\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/TNDM-DEADLINE-ALERT-ROSEN-NATIONAL-TRIAL-LAWYERS-Encourages-Tandem-Diabetes-Care-Inc-Investors-45263739/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-11-07T19:27:03Z",
            "content": "NEW YORK, Nov. 7, 2023 /PRNewswire/ --\r\nWHY:\u00a0Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 an\u2026 [+5061 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Tandem Diabetes Care : Management Change/Compensation - Form 8-K",
            "description": "(marketscreener.com) \n Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.\n \n \n \n \n \n \n On November 7, 2023, Tandem Diabetes Care, Inc. and David B. Berge\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-13T11:06:07Z",
            "content": "<table><tr><th>Date</th><th>Price</th><th>Change</th><th>Volume</th></tr>\r\n<tr><td>\r\n 23-11-10\r\n </td><td>14.28</td><td>-2.59%</td><td>\r\n 1,681,171 </td></tr><tr><td>\r\n 23-11-09\r\n </td><td>14.66</td>\u2026 [+373 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Robbins Geller Rudman & Dowd LLP",
            "title": "TUESDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TNDM",
            "description": "SAN DIEGO, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, all dates inclusive (the \u201cClass Period\u201d),\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/05/2773650/0/en/TUESDAY-INVESTOR-DEADLINE-Robbins-Geller-Rudman-Dowd-LLP-Announces-that-Tandem-Diabetes-Care-Inc-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit-TND.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/831eaafc-5ab8-455b-9219-4d3a789519aa",
            "publishedAt": "2023-11-05T21:45:00Z",
            "content": "SAN DIEGO, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman &amp; Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022\u2026 [+4144 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Law Offices of Vincent Wong",
            "title": "SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Tandem Investors of a Lead Plaintiff Deadline of November 7, 2023",
            "description": "NEW YORK, Nov.  07, 2023  (GLOBE NEWSWIRE) -- Attention Tandem Diabetes Care, Inc. (\"Tandem\") (NASDAQ: TNDM) shareholders:  The Law Offices of Vincent...",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2775518/31847/en/SHAREHOLDER-ALERT-The-Law-Offices-of-Vincent-Wong-Remind-Tandem-Investors-of-a-Lead-Plaintiff-Deadline-of-November-7-2023.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/9fbb047b-56d4-4aa2-82c8-d44e245362e2",
            "publishedAt": "2023-11-07T20:43:00Z",
            "content": "NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Attention Tandem Diabetes Care, Inc. (\"Tandem\") (NASDAQ: TNDM) shareholders:\r\nThe Law Offices of Vincent Wong announce that a class action lawsuit has comm\u2026 [+2029 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up to $14.28",
            "description": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $14.28, but opened at $14.69. Tandem Diabetes Care shares last traded at $15.44, with a volume of 239,588 shares tradi\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/tandem-diabetes-care-nasdaqtndm-shares-gap-up-to-14-28/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tandem-diabetes-care-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T16:46:55Z",
            "content": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $14.28, but opened at $14.69. Tandem Diabetes Care shares \u2026 [+3761 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 4%",
            "description": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) rose 4% on Monday . The company traded as high as $19.93 and last traded at $19.82. Approximately 799,810 shares were traded during trading, a decline of 42% from the average daily volume of 1,378,346\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/tandem-diabetes-care-nasdaqtndm-stock-price-up-4/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tandem-diabetes-care-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T23:20:47Z",
            "content": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) rose 4% on Monday . The company traded as high as $19.93 and last traded at $19.82. Approximately 799,810 shares were traded during trading,\u2026 [+5767 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Tandem Diabetes Care : Material Event - Form 8-K",
            "description": "(marketscreener.com) \n Item 8.01 Other Events.\n \n \n \n \n \n \n On November 3, 2023, the U.S. Food and Drug Administration cleared our 510 applications for our t:slim X2 insulin pump and enhancements to our Control-IQ technology with expanded pediatric indication\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Tandem-Diabetes-Care-Material-Event-Form-8-K-45247212/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-06T11:05:06Z",
            "content": "Disclaimer\r\nTandem Diabetes Care Inc. published this content on 06 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 \u2026 [+26 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Insider Buying: Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Insider Buys $29,876.40 in Stock",
            "description": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) insider Shannon Marie Hansen acquired 1,935 shares of Tandem Diabetes Care stock in a transaction that occurred on Wednesday, November 8th. The stock was bought at an average price of $15.44 per share\u2026",
            "url": "https://www.etfdailynews.com/2023/11/16/insider-buying-tandem-diabetes-care-inc-nasdaqtndm-insider-buys-29876-40-in-stock/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tandem-diabetes-care-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-16T13:02:45Z",
            "content": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) insider Shannon Marie Hansen acquired 1,935 shares of Tandem Diabetes Care stock in a transaction that occurred on Wednesday, November 8th. \u2026 [+4366 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Paradice Investment Management LLC Invests $30.11 Million in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)",
            "description": "Paradice Investment Management LLC purchased a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,226,815 shares of the \u2026",
            "url": "https://www.etfdailynews.com/2023/11/06/paradice-investment-management-llc-invests-30-11-million-in-tandem-diabetes-care-inc-nasdaqtndm/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tandem-diabetes-care-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-06T15:42:42Z",
            "content": "Paradice Investment Management LLC purchased a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Free Report) during the 2nd quarter, according to the company in its most recent Form 13F fili\u2026 [+4966 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "The Law Offices of Vincent Wong Remind Tandem Investors of a Lead Plaintiff Deadline of November 7, 2023",
            "description": "(marketscreener.com) \n\nNEW YORK, Nov. 6, 2023 /PRNewswire/ -- Attention Tandem Diabetes Care, Inc. shareholders:\n\nThe Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between August 3, 2022 an\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/The-Law-Offices-of-Vincent-Wong-Remind-Tandem-Investors-of-a-Lead-Plaintiff-Deadline-of-November-7-45247031/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-06T10:46:14Z",
            "content": "NEW YORK, Nov. 6, 2023 /PRNewswire/ -- Attention Tandem Diabetes Care, Inc. (\"Tandem\") (NASDAQ: TNDM) shareholders:\r\nThe Law Offices of Vincent Wong announce that a class action lawsuit has commenced\u2026 [+2274 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives $42.81 Consensus PT from Brokerages",
            "description": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) has been given an average recommendation of \u201cHold\u201d by the fourteen brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rati\u2026",
            "url": "https://www.etfdailynews.com/2023/11/10/tandem-diabetes-care-inc-nasdaqtndm-receives-42-81-consensus-pt-from-brokerages/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tandem-diabetes-care-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-10T13:00:43Z",
            "content": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) has been given an average recommendation of \u201cHold\u201d by the fourteen brokerages that are currently covering the company, MarketBeat.com report\u2026 [+3825 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Capital World Investors Buys 529,497 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)",
            "description": "Capital World Investors raised its stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Free Report) by 8.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned\u2026",
            "url": "https://www.etfdailynews.com/2023/11/25/capital-world-investors-buys-529497-shares-of-tandem-diabetes-care-inc-nasdaqtndm/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tandem-diabetes-care-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-25T14:12:42Z",
            "content": "Capital World Investors raised its stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Free Report) by 8.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securiti\u2026 [+6289 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Tandem Diabetes Care (NASDAQ:TNDM) Hits New 1-Year Low at $14.18",
            "description": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) shares reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $14.18 and last traded at $14.27, with a volume of 64209 shares. The stock had previously closed at $14.6\u2026",
            "url": "https://www.etfdailynews.com/2023/11/10/tandem-diabetes-care-nasdaqtndm-hits-new-1-year-low-at-14-18/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tandem-diabetes-care-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-10T16:21:00Z",
            "content": "Tandem Diabetes Care, Inc. (NASDAQ:TNDM \u2013 Get Free Report) shares reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $14.18 and last traded at $14.27, with a volu\u2026 [+3904 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Pomerantz LLP",
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims\u00a0On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\u201cTandem\u201d or the \u201cCompany\u201d) (NASDAQ:\u00a0TNDM).\u00a0\u00a0 Such investors are advised to contact Robert S. Willoughby at \u00a0newaction@pomla\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/05/2773653/1087/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Tandem-Diabetes-Care-Inc-TNDM.html",
            "urlToImage": null,
            "publishedAt": "2023-11-05T21:51:00Z",
            "content": "NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (Tandem or the Company) (NASDAQ:\u00a0TNDM).\u00a0\u00a0 Such investors are adv\u2026 [+1773 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)",
            "description": "(marketscreener.com) \nThe Law Offices of Frank R. Cruz reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Tandem Diabetes Care, Inc. securities between Augu\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/The-Law-Offices-of-Frank-R-Cruz-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-A-45250745/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-11-06T16:01:02Z",
            "content": "The Law Offices of Frank R. Cruz reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Tandem Diabe\u2026 [+2875 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Infusion Pump Market Size To Worth USD 27.92 Billion by 2032 | CAGR of 7.6%",
            "description": "The Global Infusion Pump Market Size was valued at USD 13.42 Billion in 2022 and the Worldwide Infusion Pump Market Size is expected to reach USD 27.92 Billion by 2032, according to a research report published by Spherical Insights & Consulting. Companies Cov\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2784046/0/en/Global-Infusion-Pump-Market-Size-To-Worth-USD-27-92-Billion-by-2032-CAGR-of-7-6.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-21T13:30:00Z",
            "content": "New York, United States, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The Global Infusion Pump Market Size is To Grow from USD 13.42 Billion in 2022 to USD 27.92 Billion by 2032, at a Compound Annual Growth Rat\u2026 [+10580 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Portnoy Law",
            "title": "Tandem Diabetes Care, Inc investors: Please contact the Portnoy Law Firm to recover your losses; November 2, 2023 deadline",
            "description": "Investors can contact the law firm at no cost to learn more about recovering their losses  LOS ANGELES, Nov.  07, 2023  (GLOBE NEWSWIRE) -- The Portnoy...",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2775526/0/en/Tandem-Diabetes-Care-Inc-investors-Please-contact-the-Portnoy-Law-Firm-to-recover-your-losses-November-2-2023-deadline.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ea0dd9c0-6e41-4d5a-ad27-b277677af6df",
            "publishedAt": "2023-11-07T20:47:00Z",
            "content": "Investors can contact the law firm at no cost to learn more about recovering their losses\r\nLOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Tandem Diabetes Care, Inc. (Tand\u2026 [+2347 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Historic Victory as People With Diabetes Win Access to Life-Changing Technology, But Almost Half Don't Understand the Benefits1-2",
            "description": "(marketscreener.com) \n\nNew NICE recommendations demonstrate significant benefits of hybrid closed loop systems \u2013 a form of automated insulin delivery with minimal user interaction \u2013 for people with diabetes3.\n\n\n\nHCL systems, powered by Dexcom CGM, can signifi\u2026",
            "url": "https://www.marketscreener.com/quote/stock/DEXCOM-INC-9115/news/Historic-Victory-as-People-With-Diabetes-Win-Access-to-Life-Changing-Technology-But-Almost-Half-Don-45269384/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-08T09:01:02Z",
            "content": "New NICE recommendations demonstrate significant benefits of hybrid closed loop systems (HCL) a form of automated insulin delivery with minimal user interaction for people with diabetes3.\r\nHCL system\u2026 [+8056 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vantage Market Research",
            "title": "With 15.60% CAGR, Insulin Pump Market Size Worth $14.73 Billion by 2030 | Vantage Market Research",
            "description": "WASHINGTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Global Insulin Pump Market achieved a valuation of $4.62 Billion in 2022 and is anticipated to exceed $14.73 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 15.60% during the forecast per\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2787112/0/en/With-15-60-CAGR-Insulin-Pump-Market-Size-Worth-14-73-Billion-by-2030-Vantage-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b992ad70-52a5-4308-9ec3-ec32ebfecaee",
            "publishedAt": "2023-11-28T14:50:00Z",
            "content": "WASHINGTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Global Insulin Pump Market achieved a valuation of $4.62 Billion in 2022 and is anticipated to exceed $14.73 Billion by 2030, reflecting a compounded\u2026 [+11487 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Law Offices of Frank R. Cruz",
            "title": "DEADLINE ALERT for PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders",
            "description": "LOS ANGELES, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.\u00a0 Investors have until the deadlines listed below\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/06/2774256/0/en/DEADLINE-ALERT-for-PATH-TNDM-and-LESL-The-Law-Offices-of-Frank-R-Cruz-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/778ea178-25d1-48a3-9141-a162814899d4",
            "publishedAt": "2023-11-06T15:12:00Z",
            "content": "LOS ANGELES, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded\u2026 [+5680 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Zoe Bradfield, Emily Leefhelm, Sze-Ee Soh, Kirsten I. Black, Jacqueline A. Boyle, Lesley Kuliukas, Cheryce Harrison, Caroline S. E. Homer, Rachel M. Smith, Helen Skouteris",
            "title": "The MidPIC study: Midwives\u2019 knowledge, perspectives and learning needs regarding preconception and interconception care",
            "description": "Preconception and interconception care improves health outcomes of women and communities. Little is known about how prepared and willing Australian midwives are to provide preconception and interconception care. The aim of this study was to explore midwives\u2019 \u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0289910",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0289910.g007&size=inline",
            "publishedAt": "2023-11-09T14:00:00Z",
            "content": "Abstract\r\nPreconception and interconception care improves health outcomes of women and communities. Little is known about how prepared and willing Australian midwives are to provide preconception and\u2026 [+51555 chars]"
        }
    ]
}